Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer -: Discussion

被引：0
|
作者：
Chambers, Setsuko K.
Page
机构：
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2007年 / 196卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
    Page, John G.
    Tian, Baohong
    Schweikart, Karen
    Tomaszewski, Joseph
    Harris, Ray
    Broadt, Trevor
    Polley-Nelson, Judith
    Noker, Patricia E.
    Wang, Minghui
    Makhija, Sharmila
    Aurigemma, Rose
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04) : 389.e1 - 389.e10
  • [2] Identifying the safety profile of Ad5/3-Δ24, a novel infectivity-enhanced conditionally replicative adenovirus, in anticipation of a phase I clinical trial in patients with ovarian cancer
    Kim, K.
    Tosca, P.
    Rudge, T.
    Peggins, J.
    Broadt, T.
    Wang, M.
    Harris, R.
    Aurigemma, R.
    Curiel, D.
    Alvarez, R.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S150 - S151
  • [3] Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
    Matthews, Kellie
    Noker, Patricia E.
    Tian, Baohong
    Grimes, Sheila D.
    Fulton, Ronna
    Schweikart, Karen
    Harris, Raymond
    Aurigemma, Rose
    Wang, Minghui
    Barnes, Mack N.
    Siegal, Gene P.
    Hemminki, Akseli
    Zinn, Kurt
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4131 - 4137
  • [4] Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer and other selected gynecologic cancers
    Matthews, K. S.
    Noker, P.
    Tian, B.
    Grimes, S.
    Fulton, R.
    Schweikart, K.
    Harris, R.
    Aurigemma, R.
    Wang, M.
    Curiel, D. T.
    Alvarez, R. D.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S111 - S112
  • [5] A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
    Kim, Kenneth H.
    Dmitriev, Igor P.
    Saddekni, Souheil
    Kashentseva, Elena A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Bae, Sejong
    Singh, Karan P.
    Siegal, Gene P.
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 518 - 524
  • [6] A phase I study of the infectivity enhanced CRAd Ad5-Δ 24RGD for recurrent gynecologic cancer
    Curiel, D. T.
    Preuss, M.
    Wang, M.
    Kimball, K. J.
    Barnes, M. N.
    Wan, W.
    Siegal, G.
    Harris, R.
    Aurigemma, R.
    Alvarez, R. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Δ24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients
    Kim, Kenneth H.
    Ryan, Michael J.
    Estep, James E.
    Miniard, Brock M.
    Rudge, Thomas L.
    Peggins, James O.
    Broadt, Trevor L.
    Wang, Minghui
    Preuss, Meredith A.
    Siegal, Gene P.
    Hemminki, Akseli
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. HUMAN GENE THERAPY, 2011, 22 (07) : 821 - 828
  • [8] A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer
    Kim, Kenneth H.
    Dmitriev, Igor
    O'Malley, Janis P.
    Wang, Minghui
    Saddekni, Souheil
    You, Zhiying
    Preuss, Meredith A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Siegal, Gene P.
    Zinn, Kurt R.
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3440 - 3451
  • [9] Potential of the conditionally replicative adenovirus Ad5-Δ24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy
    Lamfers, MLM
    Grill, J
    Dirven, CMF
    van Beusechem, VW
    Geoerger, B
    van den Berg, J
    Alemany, R
    Fueyo, J
    Curiel, DT
    Vassal, G
    Pinedo, HM
    Vandertop, WP
    Gerritsen, WR
    [J]. CANCER RESEARCH, 2002, 62 (20) : 5736 - 5742
  • [10] A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer
    Kim, K.
    Wang, M.
    Barnes, M.
    O'Malley, J.
    You, Z.
    Preuss, M.
    Siegal, G.
    Zinn, K.
    Curie, D.
    Alvarez, R.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S31 - S31
1